Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk [Phase 3]
This update notes the completion of a Phase 3 trial comparing HLA-mismatched hematopoietic stem cell transplantation to HLA-matched transpla…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment [Phase 2]
Phase 2 trial update on BI 811283 in combination with cytarabine for adults with newly diagnosed acute myeloid leukemia ineligible for inten…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: T-Cell Depleted Double UCB for Refractory AML [Phase 2]
Phase 2 trial of T-cell depleted double umbilical cord blood for refractory acute myeloid leukemia has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia [Phase 3]
Phase 3 trial evaluating prophylaxis for chronic graft-versus-host disease using anti-thymocyte globulin (ATG) prior to stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
This completed clinical trial update reports analyses of drug biomarkers in cell samples from patients with acute myeloid leukemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 trial evaluating alloreactive NK cells as an adjunct to allogeneic stem cell transplantation in patients with myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Phase 2]
This Phase 2 trial comparing Vidaza (azacitidine), MGCD0103, and their combination in elderly patients with newly diagnosed acute myeloid le…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias [Phase 1]
Phase 1 study of TH-302 (evofosfamide), a hypoxia-activated prodrug, in patients with advanced leukemias has been completed, with evaluation…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia
A completed clinical trial update reports biomarker analyses in bone marrow samples from patients with acute promyelocytic leukemia (APL). T…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Biomarkers in Young Patients With Acute Myeloid Leukemia
A completed pediatric clinical trial from the Children's Oncology Group evaluated biomarkers in young patients with acute myeloid leukemia. …
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Biomarkers in Patients With Acute Myeloid Leukemia
This document reports on a completed clinical trial evaluating biomarkers in patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial evaluating phenylbutyrate, dexamethasone, and sargramostim for refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML [Phase 2, Phase 3]
This clinical trial update discusses the use of granulocyte colony stimulating factor (G-CSF) after salvage chemotherapy in patients with re…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
This Phase 1 trial update reports on the use of sorafenib in patients with refractory or relapsed acute leukemia, myelodysplastic syndromes,…
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant [Phase 1]
This Phase 1 trial investigates azacitidine after chemotherapy and donor lymphocyte infusion in patients with relapsed acute myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML [Phase 1]
Phase 1 trial evaluating allogeneic stem cell transplantation in high-risk CD33+ acute myeloid leukemia, myelodysplastic syndrome, and juven…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients
Clinical trial update comparing idarubicin to daunorubicin in acute myeloid leukemia reports higher induction remission rates and better res…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [Phase 1]
This update summarizes a Phase 1 study of tipifarnib and bortezomib in patients with acute leukemia and blast-phase chronic myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia [Phase 1]
A Phase 1 safety study evaluating intravenous tigecycline for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants [Phase 2]
A Phase 2 clinical trial evaluating a sirolimus-tacrolimus combination following HLA-matched related peripheral blood stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Dose-reduced Versus Standard Conditioning in MDS/sAML [Phase 3]
Phase 3 trial comparing dose-reduced versus standard conditioning in myelodysplastic syndromes and secondary acute myeloid leukemia was term…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable [Phase 2]
This document reports the results of a Phase 2 trial evaluating clofarabine in older patients with acute myeloid leukemia who are not suitab…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia [Phase 2]
Phase 2 pilot trial evaluating erlotinib for de novo acute myeloid leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Investigation of Clofarabine in Acute Leukemias [Phase 2]
Phase 2 trial of clofarabine in acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myelogenous leukemia has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
A Phase 1 study of combining Plerixafor with cytarabine and daunorubicin in adults with newly diagnosed acute myeloid leukemia has completed…